Fresh analysis indicates that patients who discontinue blockbuster GLP-1 drugs like semaglutide or tirzepatide can put back on lost weight far faster than those who halt conventional diet and exercise regimens.
Published data in a leading health publication shows that while obese people often shed substantial amounts of their body weight while using the jabs, the mass returns at an estimated rate of nearly a kilo each month after stopping.
"Users purchasing such drugs should be aware of the potential of quick weight regain when the therapy concludes," warns lead investigator Dr. Susan Jebb.
That rate of regain suggests a return to pre-treatment mass in about a year and a half.
Comparing Approaches
The research, which reviewed dozens of trials involving over 9,000 of participants, contrasted the results of GLP-1 agonists with other pills.
The team point out that individuals who shed pounds through lifestyle changes alone generally experience a less rapid weight regain—perhaps 100 grams monthly—after stopping.
Explaining the Rapid Rebound
Nutrition scientists propose the way of the jabs is key to understanding the heightened weight return.
These medications copy a body's own chemical called glucagon-like peptide-1, which controls appetite.
"Artificially providing the hormone levels several times higher than normal could lead to the body to produce less of its own natural hormone, and could diminish sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Stopping of this hormone supplement results in hunger is no longer kept in check, making excessive eating far more likely."
A Lifelong Condition?
Health authorities suggest the injections for individuals with obesity-related health risks, alongside prescribed lifestyle changes.
Many experts argue that, due to the high risk of weight regain, the therapy is often ongoing.
This view is reinforced by pharmaceutical companies, who say that the findings "highlight the long-term nature of excess weight," comparing it to managing diseases like diabetes.
User Testimonies
People who have discontinued the jabs report a intense return of hunger.
"It was like a trigger that goes on and you're instantly extremely hungry," recalled one woman.
This difficulty is compounded if individuals have not adopted sustainable lifestyle or habit changes during treatment.
Widespread Use
Figures suggest that millions of people in the UK have used weight-loss jabs in the past year, with interest remaining high.
- Adoption is greater among women than men.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion obtain the medications through private healthcare rather than the NHS.
Ultimately, clinicians emphasize that while these medications are effective tools for shedding pounds, they are not a standalone solution and maintained weight loss relies on integrated lifestyle changes.
